Celltech Group (NYSE: CLL) Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Celltech Group (NYSE: CLL)

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: keokalani'nui who wrote (53)	10/19/2002 3:35:47 PM
From: nigel bates	Read Replies (1) of 123

Sorry, not yet. If I get the time next week, will do some digging. (edit) 8 hrs :-) Celltech R&D Briefing Meeting Agenda Start Time (UK Time) Presentation Speaker 0900-0920 Introduction, overview of Celltech R&D Dr Melanie Lee R&D Director 0920-0945 Development pipeline Dr Patrick Round Development Director 0945-1000 Q&A’s 1000-1025 Small molecule drug research at Celltech Dr David Simmons Research Director, Cambridge 1025-1050 CDP323: novel anti-inflammatory agent Dr Roly Foulkes Director of Pharmacology and DMPK 1050-1100 Q&A’s 1100-1120 Break 1120-1220 Antibody pipeline and technologies Dr Neil Weir Research Director, Slough 1220-1245 Commercial profile of inflammation portfolio Michael Earl Commercial Development Director 1245-1300 Q&A’s 1300-1400 Lunch break 1400-1425 Discovery & validation of new therapeutic targets Dr Randall Schatzman Senior VP, Seattle 1425-1450 SLAM technology Dr Fred Ramsdell Director, SLAM 1450-1500 Q&A’s 1500-1530 Break 1530-1630 Oncology Dr Karen Zinkewich-Peotti Head of Oncology 1630-1700 Q&A’s

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next